Leukemia Clinical Trials in San Antonio

Showing 461-480 of 564 trials

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

NCT01534715

The purpose of this study is to test the safety and tolerability of IMGN529 in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL).

Lymphoma, Non-HodgkinChronic Lymphocytic Leukemia

ImmunoGen, Inc.49 participantsStarted Jan 2012

Boston, Massachusetts, United States • New York, New York, United States • Columbus, Ohio, United States +4 more locations

TERMINATEDPHASE3< 1 mile

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

NCT01281254

To determine if AMG 386 plus pegylated liposomal doxorubicin (PLD) is superior to placebo plus PLD as measured by progression-free survival (PFS) The hypothesis for this study is that AMG 386 plus PLD will prolong PFS compared to placebo plus PLD in women with recurrent partially platinum sensitive or resistant epithelial ovarian, primary peritoneal or fallopian tube cancer.

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer

Amgen223 participantsStarted Apr 2011

Los Angeles, California, United States • San Francisco, California, United States • Norwalk, Connecticut, United States +103 more locations

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Leukemia Trials in Other Cities

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)

Other Conditions in San Antonio